Delirium Reduction by Volatile Anesthesia in Cardiac Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

405

Participants

Timeline

Start Date

January 9, 2019

Primary Completion Date

January 11, 2024

Study Completion Date

January 11, 2024

Conditions
Delirium
Interventions
DRUG

Volatile agent

Patients will receive volatile agent to provide general anaesthesia, including CPB period. Volatile agents will be administered from anesthesia induction to the end of surgery. Concentration (MAC) of volatile agent will be selected by anaesthesiologist according to clinical situation and patient features.

DRUG

Propofol

Patients will receive propofol and no volatile agent. Propofol will be used for induction and maintenance of anesthesia.

Trial Locations (5)

117997

National Medical Research Center for Surgery named after A.V. Vishnevsky, Ministry of Health of the Russian Federation, Moscow

630055

Meshalkin Research Institute of Pathology of Circulation, Novosibirsk

Unknown

M.F. Vladimirsky Moscow Regional Research and Clinical Institute (MONIKI), Moscow

Saint Petersburg State University Hospital, Saint Petersburg

Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk

All Listed Sponsors
lead

Meshalkin Research Institute of Pathology of Circulation

NETWORK

NCT03729011 - Delirium Reduction by Volatile Anesthesia in Cardiac Surgery | Biotech Hunter | Biotech Hunter